InsidersTradesSigma
Browse the complete record of transactions filed by Nikolaj Arrild Sørensen, Chief Executive Officer. Director active across 2 companies, notably Orexo AB. Cumulatively, 3 reports have been published. Activity tracked since 11 April 2025. The latest transaction was disclosed on 2 September 2025 (Purchase). Regulator: FIN-FSA. All data is accessible without signup.
3 of 3 declarations
Nikolaj Arrild Sørensen is the CEO of Orexo AB. He is responsible for the strategic direction of the company and the day-to-day management of operations. With a strong background in the pharmaceutical sector, Nikolaj is committed to promoting innovation and achieving Orexo's growth objectives. His leadership is crucial for the development of new treatments and meeting patient needs.